Pricing Log in Create free account

Aardvark Therapeutics, Inc. (AARD) vs Neumora Therapeutics, Inc. (NMRA)

Aardvark Therapeutics, Inc. and Neumora Therapeutics, Inc. are both Biotechnology companies. Aardvark Therapeutics, Inc. and Neumora Therapeutics, Inc. are of similar size ($84.5M and $80.2M). Across the 10 metrics below, Aardvark Therapeutics, Inc. leads on 8 and Neumora Therapeutics, Inc. on 2.

Valuation

Metric AARD NMRA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 1.10 1.95 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (84.92%) (261.70%) (33.15%)
Free cash flow yield (84.17%) (207.20%) (25.50%)

Profitability

Metric AARD NMRA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (66.02%) (187.11%) (56.36%)
Return on assets (61.06%) (121.89%) (48.04%)
Return on invested capital (4,986.18%) 0.00% 0.00%

Growth

Metric AARD NMRA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 43.11% 5.23% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric AARD NMRA Biotechnology median
Debt to equity 0.00 1.19 0.00
Current ratio 12.63 4.50 4.72
Net debt to EBITDA 1.72 0.53 0.96

Dividend

Metric AARD NMRA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AARD NMRA Biotechnology median
Market cap 84.47m 80.23m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack